What is the appropriate management for an adult with a new partial (focal) seizure?

Management of New-Onset Partial (Focal) Seizure in Adults

For an adult presenting with a new-onset partial seizure, initiate antiseizure medication after a second unprovoked seizure with either lamotrigine or levetiracetam as first-line monotherapy, while simultaneously investigating the underlying etiology through neuroimaging and EEG.

Initial Evaluation and Workup

When an adult presents with a first partial seizure, immediate diagnostic evaluation is critical before deciding on treatment:

• Neuroimaging: Obtain CT head acutely in the emergency setting to rule out structural lesions, hemorrhage, or mass effect 1
• MRI brain: Recommended as follow-up imaging for all new-onset seizures unrelated to trauma, alcohol, or drugs, as it provides superior detail for identifying epileptogenic lesions 1
• EEG: Essential for confirming epileptiform activity and characterizing seizure type 1
• Laboratory evaluation: Check for metabolic disturbances, electrolyte abnormalities, drug/alcohol levels, and other provoked causes 1

The distinction between provoked (metabolic disturbances, CNS infections, stroke, drug withdrawal, trauma) versus unprovoked seizures fundamentally changes management, as provoked seizures may not require chronic antiseizure medication 1.

When to Initiate Antiseizure Medication

The occurrence of a single unprovoked seizure does not automatically necessitate starting an antiseizure drug 1. The decision hinges on recurrence risk:

• After first unprovoked seizure: Most patients should start treatment following a second focal seizure 2
• High-risk features that may warrant treatment after first seizure include:
  • Structural brain lesion on imaging
  • Epileptiform abnormalities on EEG
  • Significant neurological deficit
  • Patient preference after shared decision-making

First-Line Monotherapy Options

Preferred Agents

Lamotrigine and levetiracetam represent the best-supported first-line options for new-onset focal epilepsy in adults 3:

• Lamotrigine (Level B recommendation): Should be considered for decreasing seizure frequency in adults with new-onset focal epilepsy 3

  • Particularly effective in older adults ≥60 years (Level B) 3
  • Requires slow titration to avoid serious rash (Stevens-Johnson syndrome risk)
  • Generally well-tolerated with favorable cognitive profile

• Levetiracetam (Level C recommendation): May be considered for new-onset focal epilepsy 3

  • Advantage of rapid titration without need for slow dose escalation
  • No drug-drug interactions
  • Can be loaded if urgent seizure control needed
  • Watch for psychiatric side effects (irritability, depression)

• Carbamazepine: Remains a good initial monotherapy option based on extensive historical evidence 2

  • Effective but more drug interactions and side effects than newer agents
  • Requires monitoring for hyponatremia, especially in elderly

Additional Options

• Zonisamide (Level C): May be considered 3
• Gabapentin (Level C): May be considered specifically in patients ≥60 years old 3

Special Population: Older Adults (≥60 years)

For elderly patients with new-onset focal epilepsy, lamotrigine (Level B) or gabapentin (Level C) should be prioritized due to better tolerability profiles and evidence in this age group 3.

Critical Caveats and Pitfalls

Women of Childbearing Age

Particular attention must be paid to young women of childbearing potential 4:

• Avoid valproic acid due to high teratogenicity risk
• Counsel regarding potential teratogenic effects of all antiseizure medications
• Consider lamotrigine or levetiracetam as safer options
• Discuss contraception and pregnancy planning

What NOT to Do

• Do not prescribe benzodiazepines or antiseizure medications for functional (psychogenic) seizures without co-occurring epilepsy 5
• Do not start treatment reflexively after a single provoked seizure once the provoking factor is addressed
• Avoid polytherapy initially—start with monotherapy and optimize dosing before adding second agent

Driving Restrictions

Patients must be counseled against driving until seizure-free for at least 3 months 1. State laws vary, but this represents a minimum safe period. Document this counseling clearly.

Refractory Cases

If seizures persist despite optimal monotherapy dosing, consider:

• Switching to alternative monotherapy before adding second agent
• If truly refractory to two appropriate monotherapy trials, add adjunctive therapy from the expanding list of newer antiseizure medications 2
• Refer for epilepsy surgery evaluation if focal epilepsy remains drug-resistant, as resective surgery offers potential cure 6, 4
• Alternative options include vagus nerve stimulation or ketogenic diet in selected cases 6

Monitoring and Follow-up

• Assess seizure control and medication tolerability at regular intervals
• Monitor for psychiatric comorbidities (depression, anxiety) which are common 5
• Consider medication withdrawal only after prolonged seizure-free period (typically 2+ years) with careful risk-benefit discussion

The key principle is matching drug characteristics to patient characteristics—considering age, sex, comorbidities, and drug interaction potential—while prioritizing lamotrigine or levetiracetam as first-line agents based on the strongest available evidence 3.